Pharmacy Times March 3, 2025
Alexandra Gerlach, Associate Editor

Key Takeaways

  • The FDA’s annual flu vaccine meeting was canceled without rescheduling, raising concerns about future vaccine policy decisions.
  • The CDC’s “Wild to Mild” campaign, aimed at promoting flu vaccination, was canceled, potentially increasing vaccine hesitancy.
  • Robert F. Kennedy, Jr.’s leadership has led to doubts about vaccine efficacy, despite evidence supporting flu vaccine effectiveness.
  • Rising influenza-associated morbidity and mortality highlight the need for continued public health education and accurate vaccine information.

The decisions were made amid the United States worst flu outbreak in over 2 decades.

The cancellation of key public health initiatives by the FDA and CDC has sparked concerns among health care leaders, highlighting the growing instability within federal health agencies under Robert F. Kennedy, Jr.’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, HHS, Public Health / COVID
Healthcare’s Hottest Trends: AI, Layoffs, and a Measles Comeback Tour
Health Risks Higher More Than Two Years After COVID-19 Infection
USAID cuts could send global health into chaos
To the Pandemic Czar: Are We Prepared to Talk About Bird Flu?
Measles outbreak continues to spike with nearly 150 reported cases

Share This Article